Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 22806405)

1.

Biodistribution studies of nanoparticles using fluorescence imaging: a qualitative or quantitative method?

Liu Y, Tseng YC, Huang L.

Pharm Res. 2012 Dec;29(12):3273-7. doi: 10.1007/s11095-012-0818-1. Epub 2012 Jul 18.

2.

Influence of polyethylene glycol density and surface lipid on pharmacokinetics and biodistribution of lipid-calcium-phosphate nanoparticles.

Liu Y, Hu Y, Huang L.

Biomaterials. 2014 Mar;35(9):3027-34. doi: 10.1016/j.biomaterials.2013.12.022. Epub 2014 Jan 2.

3.

Lipid-calcium phosphate nanoparticles for delivery to the lymphatic system and SPECT/CT imaging of lymph node metastases.

Tseng YC, Xu Z, Guley K, Yuan H, Huang L.

Biomaterials. 2014 May;35(16):4688-98. doi: 10.1016/j.biomaterials.2014.02.030. Epub 2014 Mar 6.

4.

Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for in vivo imaging of human breast cancer.

Altinoğlu EI, Russin TJ, Kaiser JM, Barth BM, Eklund PC, Kester M, Adair JH.

ACS Nano. 2008 Oct 28;2(10):2075-84. doi: 10.1021/nn800448r.

PMID:
19206454
5.

Cyclo(Cys-Arg-Gly-Asp-Cys)-Gly-Lys-Cy5.5.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2011 Oct 17 [updated 2012 Feb 02].

6.

Absorption reconstruction improves biodistribution assessment of fluorescent nanoprobes using hybrid fluorescence-mediated tomography.

Gremse F, Theek B, Kunjachan S, Lederle W, Pardo A, Barth S, Lammers T, Naumann U, Kiessling F.

Theranostics. 2014 Jul 26;4(10):960-71. doi: 10.7150/thno.9293. eCollection 2014.

7.

Ultrabright and ultrastable near-infrared dye nanoparticles for in vitro and in vivo bioimaging.

Yang Y, An F, Liu Z, Zhang X, Zhou M, Li W, Hao X, Lee CS, Zhang X.

Biomaterials. 2012 Nov;33(31):7803-9. doi: 10.1016/j.biomaterials.2012.07.006. Epub 2012 Jul 21.

PMID:
22819497
8.

Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure.

Lee CM, Jeong HJ, Yun KN, Kim DW, Sohn MH, Lee JK, Jeong J, Lim ST.

Int J Nanomedicine. 2012;7:3203-9. doi: 10.2147/IJN.S32828. Epub 2012 Jun 27.

9.
10.

Imaging human pancreatic cancer xenografts by targeting mutant KRAS2 mRNA with [(111)In]DOTA(n)-poly(diamidopropanoyl)(m)-KRAS2 PNA-D(Cys-Ser-Lys-Cys) nanoparticles.

Amirkhanov NV, Zhang K, Aruva MR, Thakur ML, Wickstrom E.

Bioconjug Chem. 2010 Apr 21;21(4):731-40. doi: 10.1021/bc900523c.

PMID:
20232877
11.

Multimodality nuclear and fluorescence tumor imaging in mice using a streptavidin nanoparticle.

Liang M, Liu X, Cheng D, Liu G, Dou S, Wang Y, Rusckowski M, Hnatowich DJ.

Bioconjug Chem. 2010 Jul 21;21(7):1385-8. doi: 10.1021/bc100081h.

PMID:
20557066
12.

Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging.

Ashokan A, Gowd GS, Somasundaram VH, Bhupathi A, Peethambaran R, Unni AK, Palaniswamy S, Nair SV, Koyakutty M.

Biomaterials. 2013 Sep;34(29):7143-57. doi: 10.1016/j.biomaterials.2013.05.077. Epub 2013 Jun 21.

PMID:
23791501
13.

ZW800-1, a zwitterionic near-infrared fluorophore, and its cyclic RGD peptide derivative cyclo-(RGDyK)-ZW800-1.

Chopra A.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2013 Feb 12 [updated 2013 Feb 28].

14.

Quantitative whole body biodistribution of fluorescent-labeled agents by non-invasive tomographic imaging.

Vasquez KO, Casavant C, Peterson JD.

PLoS One. 2011;6(6):e20594. doi: 10.1371/journal.pone.0020594. Epub 2011 Jun 22.

15.

LipImage™ 815: novel dye-loaded lipid nanoparticles for long-term and sensitive in vivo near-infrared fluorescence imaging.

Jacquart A, Kéramidas M, Vollaire J, Boisgard R, Pottier G, Rustique E, Mittler F, Navarro FP, Boutet J, Coll JL, Texier I.

J Biomed Opt. 2013 Oct;18(10):101311. doi: 10.1117/1.JBO.18.10.101311.

PMID:
23900442
16.

Effect of particle size on the biodistribution of lipid nanocapsules: comparison between nuclear and fluorescence imaging and counting.

Hirsjärvi S, Sancey L, Dufort S, Belloche C, Vanpouille-Box C, Garcion E, Coll JL, Hindré F, Benoît JP.

Int J Pharm. 2013 Sep 10;453(2):594-600. doi: 10.1016/j.ijpharm.2013.05.057. Epub 2013 Jun 4.

PMID:
23747436
17.

Lipid-PEG-folate encapsulated nanoparticles with aggregation induced emission characteristics: cellular uptake mechanism and two-photon fluorescence imaging.

Geng J, Li K, Ding D, Zhang X, Qin W, Liu J, Tang BZ, Liu B.

Small. 2012 Dec 7;8(23):3655-63. doi: 10.1002/smll.201200814. Epub 2012 Aug 15.

PMID:
22893564
18.

Cy5.5-Amino-terminal fragment of urokinase-type plasminogen activator conjugated to magnetic iron oxide nanoparticles.

Leung K.

Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013.
2009 Oct 07 [updated 2009 Dec 24].

19.

Lymphatic biodistribution of polylactide nanoparticles.

Chaney EJ, Tang L, Tong R, Cheng J, Boppart SA.

Mol Imaging. 2010 Jun;9(3):153-62. Erratum in: Mol Imaging. 2011 Feb;10(1):78.

20.

Tumor targeting chitosan nanoparticles for dual-modality optical/MR cancer imaging.

Nam T, Park S, Lee SY, Park K, Choi K, Song IC, Han MH, Leary JJ, Yuk SA, Kwon IC, Kim K, Jeong SY.

Bioconjug Chem. 2010 Apr 21;21(4):578-82. doi: 10.1021/bc900408z.

PMID:
20201550
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk